Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals

doi:10.3748/wjg.v12.i27.4359

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3533)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

342

HTML

2793

Figures (1-2)

202

Tables (1-6)

196

Sum=3533

Jul 21, 2006 (publication date) through Nov 15, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jul 21, 2006; 12(27): 4359-4363
Published online Jul 21, 2006. doi: 10.3748/wjg.v12.i27.4359

Table 1 Serum levels of TC, TG, HDL-C, LDL-C, FFA and the relative hepatic weight after treatment with osthole for 6 wk in alcohol-induced fatty liver rats (n = 10)

Group	TC (mmol/L)	TG (mmol/L)	HDL-C (mmol/L)	LDL-C (mmol/L)	FFA(μmol/L)	Relative hepatic weight (g/100 g)
Control	2.14 ± 0.28	0.40 ± 0.11	1.16 ± 0.16	0.80 ± 0.21	429.93 ± 90.28	2.36 ± 0.33
Model	2.52 ± 0.30^a	0.51 ± 0.09^a	0.96 ± 0.24^a	1.32 ± 0.51^b	535.04 ± 105.44^a	2.82 ± 0.28^b
Osthole 5 mg/kg	1.72 ± 0.18^d	0.38 ± 0.08^d	0.91 ± 0.30	0.64 ± 0.34^d	477.37 ± 109.47	2.30 ± 0.14^d
Osthole 10 mg/kg	1.69 ± 0.29^d	0.36 ± 0.11^d	1.02 ± 0.17	0.50 ± 0.17^d	473.79 ± 196.55	2.30 ± 0.12^d
Osthole 20 mg/kg	1.60 ± 0.36^d	0.37 ± 0.06^d	1.05 ± 0.15	0.43 ± 0.21^d	487.59 ± 130.79	2.37 ± 0.19^d
Lipanthyl 20 mg/kg	1.82 ± 0.28^d	0.42 ± 0.09^c	1.01 ± 0.20	0.62 ± 0.31^d	654.74 ± 136.86^c	3.45 ± 0.18^d

^aP < 0.05,

^bP < 0.01 vs control animal.

^cP < 0.05,

^dP < 0.01 vs model animal.

Table 2 Levels of TC, TG, SOD, MDA and GSH-PX in liver after treatment with osthole for 6 wk in alcohol-induced fatty liver rats (n = 10)

Group	TC (mg/g wet tissue)	TG (mg/g wet tissue)	SOD (U/mg prot)	MDA (nmol/mg prot)	GSH-PX (vigor units)
Control	1.94 ± 0.24	15.27 ± 3.35	58.33 ± 4.28	4.14 ± 1.34	174.86 ± 49.56
Model	2.25 ± 0.36^a	18.88 ± 3.81^a	50.04 ± 8.20^a	5.36 ± 0.82^a	206.80 ± 66.07
Osthole 5 mg/kg	1.82 ± 0.38^d	16.19 ± 4.21	61.11 ± 3.26^d	3.90 ± 1.35^d	203.80 ± 41.24
Osthole 10 mg/kg	1.80 ± 0.25^d	14.25 ± 3.10^d	61.45 ± 3.62^d	3.74 ± 0.99^d	182.30 ± 31.42
Osthole 20 mg/kg	1.76 ± 0.21^d	13.67 ± 4.30^d	58.91 ± 3.72^d	2.88 ± 0.92^d	171.89 ± 32.44
Lipanthyl 20 mg/kg	1.61 ± 0.20^d	12.84 ± 3.22^d	53.80 ± 2.49	2.59 ± 0.54^d	200.95 ± 55.26

^aP < 0.05, ^bP < 0.01 vs control animal. ^cP < 0.05,

^dP < 0.01 vs model animal.

Table 3 Histopathological changes of hepatic fatty degeneration after treatment with osthole 5-20 mg/kg for 6 wk in alcohol-induced fatty liver rats (n = 10)

Degreeof fattydegeneration	Control	Model	Osthole			Lipanthyl20 mg/kg
Degreeof fattydegeneration	Control	Model	5 mg/kg	10 mg/kg	20 mg/kg	Lipanthyl20 mg/kg
—	9	0	2	2	4	6
+	1	5	7	8	6	4
++	0	5	1	0	0	0
+++	0	0	0	0	0	0
P	< 0.01		< 0.05	< 0.05	< 0.01	< 0.01

P value for medicine-treated or control animal vs model animal.

Table 4 Serum levels of TC, TG, HDL-C, LDL-C, FFA and the relative hepatic weight after treatment with osthole for 6 wk in high fat-induced fatty liver quails (n = 10)

Group	TC (mmol/L)	TG (mmol/L)	HDL-C (mmol/L)	LDL-C (mmol/L)	FFA(μmol/L)	Relative hepatic weight (g/100 g)
Control	5.74 ± 0.51	0.68 ± 0.14	5.12 ± 0.48	0.31 ± 0.23	963.21 ± 231.70	1.89 ± 0.16
Model	9.53 ± 3.92^b	0.89 ± 0.21^a	5.35 ± 0.98	3.78 ± 3.36^b	1303.77 ± 372.58^a	2.13 ± 0.19^b
Osthole 5 mg/kg	7.34 ± 0.88	0.49 ± 0.08^d	5.50 ± 0.58	1.62 ± 0.73	938.68 ± 146.77^d	1.83 ± 0.11^d
Osthole 10 mg/kg	7.32 ± 1.53	0.57 ± 0.16^d	5.56 ± 0.93	1.50 ± 1.41	794.34 ± 225.05^d	1.83 ± 0.25^d
Osthole 20 mg/kg	6.89 ± 0.84^c	0.45 ± 0.05^d	5.72 ± 0.75	0.98 ± 1.19^c	783.96 ±1 04.05^d	1.78 ± 0.13^d
Lipanthyl 20 mg/kg	6.74 ± 0.73^c	0.55 ± 0.10^d	5.87 ± 0.66	0.62 ± 0.53^d	1170.75 ± 425.34	1.76 ± 0.19^d

^aP < 0.05,

^bP < 0.01 vs control animal.

^cP < 0.05,

^dP < 0.01 vs model animal.

Table 5 Levels of TC, TG, FFA, SOD, MDA and GSH-PX in liver after treatment with osthole for 6 wk in high fat-induced fatty liver quails (n = 10)

Group	TC (mg/g wet tissue)	TG (mg/g wet tissue)	FFA (mg/g wet tissue)	SOD (U/mg prot)	MDA (nmol/mg prot)	GSH-PX (vigor units)
Control	2.26 ± 0.56	11.42 ± 4.37	499.14 ± 90.73	368.10 ± 21.60	10.93 ± 2.44	121.53 ± 20.88
Model	6.94 ± 3.25^b	17.34 ± 5.90^a	418.97 ± 181.75	314.24 ± 17.91^b	11.37 ± 1.71	111.23 ± 29.85
Osthole 5 mg/kg	4.32 ± 0.69^c	16.05 ± 4.74	508.62 ± 180.05	343.20 ± 33.71^c	10.73 ± 2.30	130.00 ± 38.82
Osthole 10 mg/kg	4.05 ± 1.82^c	13.48 ± 2.55	478.45 ± 134.74	344.16 ± 10.25^d	10.86 ± 3.56	151.40 ± 41.34^c
Osthole 20 mg/kg	3.66 ± 1.14^d	12.97 ± 2.38^c	419.83 ± 106.21	353.70 ± 33.95^d	10.73 ± 0.95	174.35 ± 46.43^d
Lipanthyl 20 mg/kg	4.05 ± 1.06^c	14.87 ± 6.21	731.03 ± 237.13^d	357.98 ± 16.08^d	11.02 ± 1.90	150.05 ± 46.54^c

^cP < 0.05,

^dP < 0.01 for medicine-treated animal versus model animal.

Table 6 Histopathological changes of hepatic fatty degeneration after treatment with osthole 5-20 mg/kg for 6 wk in high fat-induced fatty liver quails (n = 10)

Degreeof fattydegeneration	Control	Model	Osthole			Lipanthyl
Degreeof fattydegeneration	Control	Model	5 mg/kg	10 mg/kg	20 mg/kg	20 mg/kg
—	10	0	3	4	7	5
+	0	4	7	6	3	4
++	0	4	0	0	0	1
+++	0	2	0	0	0	0
P	< 0.01		< 0.01	< 0.01	< 0.01	< 0.01

P value for medicine-treated or control animal vs model animal.

Citation: Song F, Xie ML, Zhu LJ, Zhang KP, Xue J, Gu ZL. Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals. World J Gastroenterol 2006; 12(27): 4359-4363
URL: https://www.wjgnet.com/1007-9327/full/v12/i27/4359.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i27.4359